Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Ursodiol products are in shortage in Canada (2 of 12 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A bile acid used to dissolve gallstones and treat certain liver diseases.
Products affected
2 / 12
In shortage since
Jul 12, 2024
Reports on file
31
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
URSODIOL C
250MG · TABLET · SANIS HEALTH INC
DIN 02515520 · since Jul 12, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
URSODIOL C
500MG · TABLET · SANIS HEALTH INC
DIN 02515539 · since Aug 1, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP-URSODIOL
250MG · TABLET · JAMP PHARMA CORPORATION
DIN 02472392 · ended Jun 15, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP-URSODIOL
250MG · TABLET · JAMP PHARMA CORPORATION
DIN 02472392 · ended Oct 3, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP-URSODIOL
250MG · TABLET · JAMP PHARMA CORPORATION
DIN 02472392 · ended Oct 3, 2025 · Disruption of the manufacture of the drug.
Resolved
GLN-URSODIOL
500MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02426919 · ended May 5, 2025 · Demand increase for the drug.
Resolved
NRA-URSODIOL
250MG · TABLET · NORA PHARMA INC
DIN 02544032 · ended Mar 24, 2025 · Demand increase for the drug.
Resolved
NRA-URSODIOL
500MG · TABLET · NORA PHARMA INC
DIN 02544024 · ended Mar 24, 2025 · Demand increase for the drug.
Resolved
GLN-URSODIOL
250MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02426900 · ended Mar 11, 2025 · Demand increase for the drug.
Resolved
GLN-URSODIOL
250MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02426900 · ended Feb 25, 2025 · Demand increase for the drug.
Resolved
JAMP-URSODIOL
500MG · TABLET · JAMP PHARMA CORPORATION
DIN 02472406 · ended Jan 21, 2025 · Disruption of the manufacture of the drug.
Resolved
GLN-URSODIOL
500MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02426919 · ended Dec 20, 2024 · Demand increase for the drug.
Showing 12 of 31 reports. All reports are on file with Health Canada.
What's happening
Ursodiol is currently affected by 2 active shortage reports filed with Health Canada by SANIS HEALTH INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ursodiol is classified under “BILE THERAPY” (ATC A05AA).
Recent changes
No changes recorded yet.
Common questions
What is Ursodiol used for?
A bile acid used to dissolve gallstones and treat certain liver diseases.
When will Ursodiol be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Ursodiol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.